C. Klebanoff

Immunology · 2003–2023

A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 151 citations into it; #1,445 of 2,160 by trust here, #498 by citations
• Oncology — 118 citations into it

Whom C. Klebanoff trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. M. Dudley
2. S. Rosenberg
3. E. Wherry

Who trusts C. Klebanoff overall

1. S. Rosenberg
2. N. Restifo
3. L. Gattinoni
4. Witold Lasek

Papers from C. Klebanoff's perspective

Ordered by how strongly the researchers C. Klebanoff trusts endorse each paper. Same corpus, a different order for every researcher.

1. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells (Proceedings of the National Academy of Sciences of the United States of America)
2. Mitochondrial Respiratory Capacity Is A Critical Regulator Of CD8+ T Cell Memory Development (Immunity)
3. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors (Nature Immunology)
4. Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment (Journal of Virology)
5. Enhancing CD8 T Cell Memory by Modulating Fatty Acid Metabolism (Nature)
6. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. (Immunity)
7. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection (Nature Immunology)
8. Tolerance, not immunity, crucially depends on IL-2 (Nature reviews. Immunology)
9. Origin of regulatory T cells with known specificity for antigen (Nature Immunology)
10. IL-2, Regulatory T Cells, and Tolerance (Journal of Immunology)

Their papers

• Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells (2003) — 1,015 citations
• Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial (2023)
• Clinical implications of T cell exhaustion for cancer immunotherapy (2022) — 846 citations
• Tumor mutational load predicts survival after immunotherapy across multiple cancer types (2019) — 3,368 citations
• TOX is a critical regulator of tumour-specific T cell differentiation (2019) — 942 citations
• Ionic immune suppression within the tumour microenvironment limits T cell effector function (2016) — 607 citations
• Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. (2013) — 897 citations
• CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cells (2005) — 792 citations
• Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. (2005) — 1,032 citations
• Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. (2005) — 992 citations
• IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells (2004) — 619 citations